Efficacy of CBT on Positive Health Outcomes of Chronic Heart Failure Patients With Depression
CaCBT
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of the study is to know the efficacy of Cognitive Behaviour Therapy on Positive Health Outcomes of Chronic Heart Failure Patients with Depression. It is a Randomized Control Trial (RCT) in which patients will be selected through purposive sampling techniques. Ages of patients will be 18-60 years. Data will be collected at outpatient department (OPD) of Ch.Pervaiz Elahi Institute of Cardiology Multan.Total measured sample size is 70 calculated by using G\*Power 3.1.9.4.Patients will be randomized into Interventional and Control group, with 1:1 allocation, 35 patients in each group by virtual randomization(www.randomization.com). Diagnosed patients of heart failure for 6 or more than 6 months duration, EF ≤ 40 % on Trans Thoracic Echocardiography, patients with NYHA Heart Failure class II and III, patients with "mild" to "severe" level of depression based on PHQ-9 .Patients with other Psychiatric Disorders except depression, any substance dependence, mentally retarded, having personality disorders, already have received any psychotherapy or any psychiatric medication will be excluded. Patients will be assessed for functional disability by WHODAS 2.0 and severity of Heart Failure will be assessed by a Cardiologist using NYHA Heart Failure classification. Patients in experimental group will receive treatment as usual (TAU) and culturally adapted Cognitive Behavior Therapy. Patients in control group will receive treatment as usual (TAU) by a Cardiologist . The aim of this experimental study is to study the efficacy of culturally adapted Cognitive Behavioral Therapy in patients with chronic heart failure with depression. To study the above-mentioned phenomenon, following hypotheses are formulated: Hypothesis 1: Patients receiving culturally adapted Cognitive-Behavioral Therapy will show reduction in their level of depression than patients not receiving intervention. Hypothesis 2: Patients will improve in NHYA heart failure class, by receiving CaCBT in experimental group as compared to control group. Hypothesis 3: Patients who will receive CaCBT will show less repeated Hospitalization in experimental group as compared to control group. Hypothesis 4: Patients in the intervention group will show betterment in the functional disability from pretest to post-test as compared to non- interventional group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 3, 2021
CompletedFirst Posted
Study publicly available on registry
July 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2021
CompletedSeptember 8, 2021
September 1, 2021
7 months
June 3, 2021
September 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in scores of depression measured by patients' health questionnaire 9
change in scores of depression will be measured by Patients' Health Questionnaire 9. The PHQ-9 total score ranges from 0 to 27 (scores of 0- 4 are classified as none,5-9 mild depression; 10-14 as moderate depression; 15-19 as moderately severe depression; 20-27 as severe depression )from baseline to 2 and half months of intervention in control and experimental group.
change from baseline scores of depression at 2 and half months of intervention in experimental and control group.
Secondary Outcomes (3)
change in functional disability by world health organization disability assessment schedule II version.
Change in functional disability scores by world health organization disability assessment schedule II version will be measured from baseline to 2 and half months of intervention in control and experimental group.
Change in New York Heart Association Classification of patients by a consultant cardiologist.
Change in class of New York Heart Association Classification of patients at 2 and half months of intervention and will be measured by a consultant cardiologist on New York Heart Association Classification in experimental and control group.
Change in number of repeated hospitalization by patients' feedback.
Change in experimental group's number of repeated hospitalization compared to control group's repeated number of hospitalization after 2 and half months of intervention.
Study Arms (2)
CHF patients who will receive guided self help culturally adapted cognitive behavioral therapy
EXPERIMENTALCHF(Chronic heart failure patients)(experimental group) will receive guided self help culturally adapted cognitive behavioral therapy.
CHF patients will not receive guided self help culturally adapted cognitive behavioral therapy
NO INTERVENTIONCHF(Chronic heart failure patients) (control group) will not receive Self Help Culturally Cognitive Behavior Therapy.
Interventions
Experimental group (CHF patients)will be screened on PHQ9 questionnaire for depression after receiving guided self help culturally adapted cognitive therapy they will be reassessed for their depression,improvement in functional disability ,improvement in classification of NYHA,reduction in hospital admission as compare to control group.
Eligibility Criteria
You may qualify if:
- Diagnosed heart failure patients for 6 and more than 6 months duration,
- EF \< 40 % on Echocardiography ,
- class II and III of NYHA heart failure,
- "mild" to "severe" depression based on patients health questionnaire 9
- who can understand, read, and write in Urdu will be included in study.
You may not qualify if:
- any psychiatric disorders except depression,
- substance dependence, mental retardation, personality disorders,
- who have had received any psychotherapy or any psychiatric medication,
- who are not willing to continue the sessions anymore, and the absence in more than two sessions will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chauhdary Pervaiz Ellahi Institute of Cardiology
Multan, Punjab Province, 60000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Student of PhD of Applied psychology
Study Record Dates
First Submitted
June 3, 2021
First Posted
July 2, 2021
Study Start
February 1, 2021
Primary Completion
September 10, 2021
Study Completion
November 29, 2021
Last Updated
September 8, 2021
Record last verified: 2021-09